QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online September 22, 2005
doi: 10.1242/10.1242/jcs.02568

This Article Summary Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlton, J. G. Articles by Cullen, P. J. Search for Related Content PubMed PubMed Citation Articles by Carlton, J. G. Articles by Cullen, P. J. Social Bookmarking                         What's this?

Sorting nexin-2 is associated with tubular elements of the early endosome, but is not essential for retromer-mediated endosome-to-TGN transport

Jez G. Carlton^1,*, Miriam V. Bujny^1,*, Brian J. Peter², Viola M. J. Oorschot³, Anna Rutherford¹, Rebecca S. Arkell⁴, Judith Klumperman³, Harvey T. McMahon² and Peter J. Cullen^1,

¹ Henry Wellcome Integrated Signalling Laboratories, Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK
² MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK
³ Cell Microscopy Center, Department of Cell Biology and Institute for Biomembranes, University Medical Centre Utrecht, Utrecht, The Netherlands
⁴ Signalling Programme, The Babraham Institute, Babraham Hall, Cambridge CB2 4AT, UK

View larger version (37K): [in a new window]   Fig. 1. SNX2 binds PtdIns(3)P and PtdIns(3,5)P2. (A) Bacterially expressed SNX2 was incubated with sucrose-loaded liposomes formed from a lipid mixture of PtdCho, PtdSer and PtdEth supplemented with 20% of the relevant phosphoinositide species. SNX2 association with pelleted liposomes was assayed by western blotting with SNX2-specific antisera. Results are representative of more than three independent experiments. (B) Relative amounts of phosphoinositides were titrated down while keeping total lipid mass constant. SNX2 association with the lipid pellet was determined by volume integration of western blots. Results were averaged for at least three separate experiments. (C) The PX domain mutant SNX2(K211A) is unable to associate with phosphoinositides. Results are representative of more than three independent experiments.

View larger version (53K): [in a new window]   Fig. 2. SNX2 is capable of sensing membrane curvature but does not induce membrane tubulation in vitro or in vivo. (A) Variously curved liposomes were formed by extrusion, and binding of proteins was assayed by sedimentation. SNX2 bound preferentially to highly curved membranes, as did SNX1. The epsin1 ENTH domain (which strongly tubulates membranes), and Dab2 (which does not change liposome shape) were insensitive to curvature. Amount of bound protein was normalised to the value for 0.8 µm liposomes. Average values for three experiments ± s.d. are shown. (B) Liposomes derived from brain were incubated with 20 µM BSA (i) or 20 µM of full length recombinant SNX1 (ii,iii) or SNX2 (iv,v). Whereas budding tubular profiles and occasionally tubular networks were observed with SNX1, no tubules were observed when using SNX2. For SNX1 (ii,iii) and SNX2 (iv,v) the data represents two independent experiments. (C). HeLa cells were transiently transfected with a construct encoding for GFP-SNX2. After 48 hours of incubation, cells expressing low and high levels of GFP-SNX2 were fixed and imaged by confocal microscopy. At low levels, SNX2 was associated with punctate cytoplasmic vesicles, which contrasted with the swollen endosomal vacuoles observed under conditions of high level expression. Bars, 10 µm.

View larger version (93K): [in a new window]   Fig. 3. At low-level expression, GFP-SNX2 is associated with elements of the early endosome. HeLa cells were transiently transfected with GFP-SNX2 and, after 24 hours, cells were fixed and stained for the early endosomal markers EEA1 (A) and SNX1 (B), internalised receptors for transferrin (C) and EGF (D), and the late endosomal marker LAMP1 (E). Images are representative of more than 10 imaged cells in each case. Bars, 10 µm.

View larger version (68K): [in a new window]   Fig. 4. In HeLa cells endogenous SNX2 and SNX1 co-localise on an early endosomal compartment. (A) HeLa cells were treated with control, SNX2-specific, SNX1-specific or both SNX2 and SNX1 siRNA duplexes for 72 hours. At this time, the levels of SNX2 and SNX1 were determined by western blotting with SNX2 or SNX1 antisera. In all cases loading was controlled by probing samples with an anti-tubulin antibody. Quantification of the data revealed that, for individual siRNA treatment using SNX2-specific or SNX1-specific duplexes, the level of SNX2 and SNX1 expression was suppressed by 82% and 93%, respectively. Under conditions of simultaneous duplex treatment, SNX2 and SNX1 were suppressed by 81% and 92%, respectively. (B) HeLa cells were treated with control, SNX2-specific, SNX1-specific or both SNX2 and SNX1 siRNA duplexes for 72 hours prior to fixation. Cells were stained for endogenous SNX1 and SNX2. Bar, 10 µm. (C) HeLa cells were fixed and co-stained with SNX1- and SNX2-specific antibodies to reveal the endogenous distribution of these proteins. Bar, 10 µm.

View larger version (120K): [in a new window]   Fig. 5. Endogenous SNX2 and SNX1 co-localise on tubular elements of the early endosome. Ultrathin cryosections of HepG2 cells showing the co-localization of SNX2 with SNX1 and CI-MPR on endosomal tubules. SNX2 (15 nm gold particles) and SNX1 (10 nm gold particles) co-localize on tubules emanating from endosomal (E) vacuoles (arrow in A) and on numerous vesicular-tubular profiles in close vicinity of endosomal vacuoles (arrows in B). SNX2 (15 nm gold particles) associates with CI-MPR (10 nm gold particles)-positive endosomal buds (arrows in C) and similar endosome-associated vesicular-tubular profiles, as shown in B (arrow in D). Bars, 200 nm

View larger version (28K): [in a new window]   Fig. 6. Suppression of SNX2 or the joint suppression of SNX2 and SNX1 has no gross affect on EGF or transferrin receptor sorting. (A) HeLa cells were treated with either control, SNX2-specific siRNA or jointly with SNX1- and SNX2-specific siRNA duplexes for 72 hours. Cells were serum-starved for 3 hours and labelled with 1 kBq per well 125I-EGF for 1 hour at 4°C, allowed to internalise surface bound 125I-EGF for 5 minutes at 37°C, and then returned to 4°C. Cells were chased into 100 ng/ml cold EGF-containing media for various times at 37°C. Recycled, degraded and internalised fractions were subjected to gamma counting. Data is the average±s.d. from three independent experiments. (B) HeLa cells were treated with control, SNX2-specific siRNA or jointly with SNX1- and SNX2-specific siRNA duplexes for 72 hours. Cells were serum-starved for 3 hours and labelled with 1 kBq per well 125I-transferrin for 60 minutes at 37°C. Cells were chased into 50 µg/ml cold transferrin-containing media for various times at 37°C. Recycled, degraded and internalised fractions were subjected to gamma counting. Data is the average±s.d. from three independent experiments. (C) Western analysis of a typical SNX1 and SNX2 suppression achieved during one of the three sets of receptor trafficking assays.

View larger version (100K): [in a new window]   Fig. 7. Endogenous SNX2 shows a high degree of co-localisation with the retromer component mVps26. (A) Co-localisation of endogenous SNX2 and endogenous mVps26. Cells were plated on coverslips, fixed and stained for SNX2 and mVps26. (B) Suppression of SNX1, SNX2, or joint suppression of both SNX1 and SNX2 does not affect mVps26 localisation. HeLa cells were treated with control, SNX1-specific siRNA, SNX2-specific siRNA or jointly with SNX1- and SNX2-specific siRNA duplexes for 72 hours. Cells were then fixed and stained against endogenous SNX1, endogenous SNX2 and endogenous mVps26. Individual or joint suppression of SNX1 and SNX2 does not affect punctate distribution of mVps26. Bars, 20 µm (A,B).

View larger version (114K): [in a new window]   Fig. 8. Suppression of SNX2 does not result in a detectable defect in the steady-state distribution of the CI-MPR. (A) HeLa cells were treated with control, SNX1-specific siRNA, SNX2-specific siRNA or jointly with SNX1- and SNX2-specific siRNA duplexes for 72 hours. Cells were fixed and stained against endogenous SNX1, endogenous SNX2 and endogenous CI-MPR. In cells subjected to RNAi against SNX2, the CI-MPR remains at a perinuclear structure that has been previously characterised as the TGN. In cells in which SNX1 and SNX2 have been suppressed, the CI-MPR undergoes a limited redistribution at steady state to peripheral structures. Bars, 20 µm. (B) HeLa cells were treated twice with control, SNX1-specific siRNA, SNX2-specific siRNA or jointly with SNX1- and SNX2-specific siRNA duplexes for two consecutive periods of 72 hours. At this time, cells were washed into cycloheximide (40 µg/ml)-containing media for 0, 4, 8 or 12 hours. Cells were lysed and the levels of endogenous CI-MPR present were resolved by western blotting with CI-MPR-specific antisera, followed by volume integration. Results are presented graphically from the averages of four independent experiments.

View larger version (88K): [in a new window]   Fig. 9. In HeLaM cells stably expressing a CD8-CI-MPR chimera, suppression of SNX2 induces a subtle change in the rate of sorting to the TGN. (A) Images depicting the kinetics of delivery of a cell-surface-labelled CD8-CI-MPR chimera to the TGN in HeLaM cells. Bars, 20 µm. (B) HeLaM cells stably expressing a CD8-CI-MPR chimera were treated with control, SNX1-specific, SNX2-specific, or SNX1- and SNX2-specific siRNA and subjected to an anti-CD8 antibody uptake experiment as described in Materials and Methods. Briefly, CD8-CI-MPR at the cell surface were labelled with anti-CD8, and allowed to internalise for 2, 8, 16 or 24 minutes. Cells were fixed and the amount of anti-CD8 that had reached the TGN46-labelled TGN was quantified by immunofluoresence using LCSLite (Leica). Results are expressed ± the s.e.m. from three independent experiments (except the 2 minute time point, which is from two independent experiments). The key indicates the siRNA treatment. (C) Western blot indicating representative levels of SNX1 and SNX2 suppression.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

Twitter